Maximizing Your Benefits: Psychedelic-assisted Therapy
What is psychedelic-assisted therapy (PaT)? Psychedelic-assisted therapy is a mental health treatment that combines psychotherapy with the controlled use of psychedelic substances. […]
Read moreCategory: ATMA News
ATMA CENA Celebrates Groundbreaking Support from Alberta Blue Cross for Psychedelic Assisted Therapies
CALGARY, March 19, 2024 – A revolutionary step in mental health care is now underway through the collaboration between ATMA Journey Centers […]
Read more
ATMA CENA Psychedelic Healthcare Solutions Opens Psychedelic-assisted Therapy Clinic in Calgary and Provides Update of Its Clinic Network
CALGARY, March 14, 2024 - ATMA CENA Psychedelic Healthcare Solutions (PHS) is a collaboration of ATMA Journey Centers Inc. (“ATMA”), Cena Life […]
Read more
ATMA and Cena Life Launch The Nationwide Psychedelic-Assisted Therapy Healthcare Network
The initial launch of 10+ network clinics aims to support practitioners in private practice to successfully provide safe and effective psychedelic-assisted therapy […]
Read more
ATMA Is Developing Clinical Protocols and Training for Ketamine-Assisted Therapy to Treat Addictions in Collaboration with Dr. Aviva Fohrer
Dr. Aviva will offer invaluable insights derived from her two decades of experience as a medical doctor specializing in addiction treatment, with […]
Read more
ATMA Welcomes Dr. Scott Shannon, MAPS MDMA Phase 3 Principal Investigator, to Expand Its’ Clinical Training Expertise in MDMA-Assisted Therapy
CALGARY, October 24, 2023 – ATMA Journey Centers Inc. (“ATMA”), a Canadian company with a primary focus on advancing psychedelic-assisted therapy, is […]
Read more
ATMA and Cena Life Announce Joint-Venture to Support Psychedelic-Assisted Therapy in Canada
ATMA and Cena Life Announce Joint-Venture to Support Psychedelic-Assisted Therapy in Canada CALGARY, October 20, 2023 - ATMA Journey Centers Inc. (“ATMA”), […]
Read more
ATMA to Provide Psychedelic-Assisted Therapy Training in French and Spanish in the Fall
CALGARY, AB, May 4, 2023 /CNW/ - ATMA Journey Centers Inc. (“ATMA”), Canada’s leading psychedelic-assisted therapy training provider, will roll out the first full psychedelic training program in […]
Read more
ATMA’s First Psychedelic Training Program for Physicians and Prescribers begins April 14, 2023
As psychedelic therapy regulations are being implemented, drafted and discussed globally, the need to educate doctors, psychiatrists and prescribers in psychedelics is greater than ever.
Read more
ATMA OFFERS PSYCHEDELIC-ASSISTED THERAPY TRAINING IN AUSTRALIA TO SUPPORT PSYCHIATRISTS AND HEALTHCARE PROFESSIONALS
In response to Australia’s approval of MDMA and psilocybin use in therapy AUSTRALIA, Feb. 7, 2023 /PRNewswire/ — ATMA Journey Centers Inc. (“ATMA”), Canada’s leading psychedelic-assisted therapy training provider, is […]
Read more